BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7616850)

  • 1. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob).
    Edvell A; Lindström P
    Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse.
    Lavine RL; Voyles N; Perrino PV; Recant L
    Am J Physiol; 1977 Aug; 233(2):E86-90. PubMed ID: 329686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin production by pancreatic islets of obese-hyperglycemic mice cultured for one week in different glucose concentrations.
    Andersson A; Asplund K; Larkins R
    Acta Physiol Scand; 1978 Dec; 104(4):377-85. PubMed ID: 364930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA replication in transplanted and endogenous pancreatic islets of obese-hyperglycemic mice at different stages of the syndrome.
    Andersson A; Korsgren O; Naeser P
    Metabolism; 1989 Oct; 38(10):974-8. PubMed ID: 2507879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
    Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell function in obese-hyperglycemic mice [ob/ob Mice].
    Lindström P
    Adv Exp Med Biol; 2010; 654():463-77. PubMed ID: 20217510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide: effects on insulin release in isolated mouse islets in relation to metabolic status and age.
    Persson-Sjögren S; Forsgren S; Lindström P
    Neuropeptides; 2006 Aug; 40(4):283-90. PubMed ID: 16797701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamines in pancreatic islets of obese-hyperglycemic (ob/ob) mice of different ages.
    Sjöholm A; Arkhammar P; Berggren PO; Andersson A
    Am J Physiol Cell Physiol; 2001 Feb; 280(2):C317-23. PubMed ID: 11208527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion.
    Chen NG; Romsos DR
    Endocrinology; 1995 Feb; 136(2):505-11. PubMed ID: 7835283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorganization of cytoplasmic Ca(2+) oscillations and pulsatile insulin secretion in islets from ob/ obmice.
    Ravier MA; Sehlin J; Henquin JC
    Diabetologia; 2002 Aug; 45(8):1154-63. PubMed ID: 12189446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse.
    Leckström A; Lundquist I; Ma Z; Westermark P
    Pancreas; 1999 Apr; 18(3):266-73. PubMed ID: 10206485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do oscillations of insulin secretion occur in the absence of cytoplasmic Ca2+ oscillations in beta-cells?
    Kjems LL; Ravier MA; Jonas JC; Henquin JC
    Diabetes; 2002 Feb; 51 Suppl 1():S177-82. PubMed ID: 11815478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob/ob mice.
    Batchelor BR; Stern JS; Johnson PR; Mahler RJ
    Metabolism; 1975 Jan; 24(1):77-91. PubMed ID: 122852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic islets of obese hyperglycemic mice (ob/ob).
    Tomita T; Doull V; Pollock HG; Krizsan D
    Pancreas; 1992; 7(3):367-75. PubMed ID: 1594559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose modulation of islet monoamine oxidase activity in lean and obese hyperglycemic mice.
    Panagiotidis G; Lindström P; Stenström A; Lundquist I
    Metabolism; 1993 Nov; 42(11):1398-404. PubMed ID: 8231833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.
    Black M; Heick HM; Bégin-Heick N
    Biochem J; 1986 Sep; 238(3):863-9. PubMed ID: 3026362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physiology of obese-hyperglycemic mice [ob/ob mice].
    Lindström P
    ScientificWorldJournal; 2007 May; 7():666-85. PubMed ID: 17619751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice.
    Carlsson PO; Andersson A; Jansson L
    Am J Physiol; 1998 Oct; 275(4):E594-601. PubMed ID: 9755077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.